Carcinogenesis Clinical Trials
2 recruiting trials for Carcinogenesis. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Carcinogenesis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Second Affiliated Hospital of Xi'an Jiaotong University (1), Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Suturing the cervical linea alba during endoscopic thyroid surgery. (procedure, 1 trial), followed by Performing transcriptome sequencing.
Track Carcinogenesis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients
The objective of this research is to investigate the clinical outcomes of modified surgical techniques such as omitting the cervical linea alba suture in transthoracic endoscopic...
Liver Disease and Other Systemic Diseases
Examine the association of chronic liver diseases (including hepatitis B, hepatitis C, alcoholic liver disease, fatty liver, liver cirrhosis, and hepatocellular carcinoma) with...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Carcinogenesis, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Carcinogenesis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Carcinogenesis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.